Zylera

Website Links

Description

For over 12 years early in his career, Mr. Jones contributed to the rapid growth and development of the Concord Group of Companies (headquartered in Denver, Colorado) where he held multiple roles as CFO and VP of Finance. In these roles he provided management support to Concord’s wholly-owned subsidiary companies across numerous industries, including domestic and international banking, mortgage banking, leasing, global nuclear fuel trading, coal and copper mining, real estate finance, manufacturing, ranching and other commercial agriculture endeavors.

Randal O. Jones is Co-Founder and Chief Financial Officer of Zylera Pharmaceuticals which is a wholly owned subsidiary of TRx Pharmaceuticals. TRx Pharmaceuticals is a specialty pharmaceutical company and technology investment company .

Matthew V. Phillips is Chief Operating Officer of Zylera Pharmaceuticals which is a wholly owned subsidiary of TRx Pharmaceuticals. TRx Pharmaceuticals is a specialty pharmaceutical company and technology investment company. Most recently Mr. Phillips served as Executive Director of Managed Markets and oversaw all aspects of Distribution, Reimbursement and Government Channels. Throughout his 20 year career in the medical/pharmaceutical industry, Mr.

Robert C. Moscato, Jr. is Co-Founder and President of Zylera Pharmaceuticals which is a wholly owned subsidiary of TRx Pharmaceuticals. TRx Pharmaceuticals is a specialty pharmaceutical company and technology investment company. Most recently he was Chief Operating Officer of Deston Therapeutics a specialty pharmaceutical company.

Products & services

Similar companies nearby